These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2242940)

  • 1. Treatment of subacute cutaneous lupus erythematosus.
    Furner BB
    Int J Dermatol; 1990 Oct; 29(8):542-7. PubMed ID: 2242940
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
    Nutan F; Ortega-Loayza AG
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S64-S68. PubMed ID: 28941497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cutaneous lupus erythematosus.
    Rothe MJ; Kerdel FA
    Lupus; 1992 Dec; 1(6):351-6. PubMed ID: 1304402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous hypertrophic lupus erythematosus: a challenging histopathologic diagnosis in the absence of clinical information.
    Arps DP; Patel RM
    Arch Pathol Lab Med; 2013 Sep; 137(9):1205-10. PubMed ID: 23991731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus".
    Callen JP
    Arch Dermatol; 2011 Nov; 147(11):1267-8. PubMed ID: 22106112
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of "refractory" skin disease in patients with lupus erythematosus.
    Callen JP
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):767-84. PubMed ID: 16150402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative management of lupus erythematosus.
    Knott HM; Martínez JD
    Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the management of cutaneous lupus erythematosus.
    Callen JP
    Br J Dermatol; 2004 Oct; 151(4):731-6. PubMed ID: 15491411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimalarials in lupus erythematosus treatment].
    Woźniacka A
    Przegl Lek; 2002; 59(3):179-82. PubMed ID: 12184034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML; McCauliffe DP
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus.
    Ezra N; Jorizzo J
    Clin Exp Dermatol; 2012 Jun; 37(4):327-34. PubMed ID: 22582908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of antimalarial-refractory cutaneous lupus erythematosus.
    Callen JP
    Lupus; 1997; 6(2):203-8. PubMed ID: 9061669
    [No Abstract]   [Full Text] [Related]  

  • 13. Poikilodermatous subacute cutaneous lupus erythematosus.
    Marzano AV; Facchetti M; Alessi E
    Dermatology; 2003; 207(3):285-90. PubMed ID: 14571071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit.
    Wozniacka A; Carter A; McCauliffe DP
    Lupus; 2002; 11(2):71-81. PubMed ID: 11958581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subacute cutaneous lupus. Evolutive and therapeutic features of a series of 24 cases].
    Versapuech J; Beylot-Barry M; Doutre MS; Beylot C
    Presse Med; 2000 Oct; 29(29):1596-9. PubMed ID: 11072357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Refractory subacute cutaneous lupus erythematosus treated with rituximab].
    Cieza-Díaz DE; Avilés-Izquierdo JA; Ceballos-Rodríguez C; Suárez-Fernández R
    Actas Dermosifiliogr; 2012; 103(6):555-7. PubMed ID: 22482740
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate treatment for refractory subacute cutaneous lupus erythematosus.
    Kuhn A; Specker C; Ruzicka T; Lehmann P
    J Am Acad Dermatol; 2002 Apr; 46(4):600-3. PubMed ID: 11907517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cutaneous lesions in patients with lupus erythematosus.
    Callen JP
    Dermatol Clin; 1990 Apr; 8(2):355-65. PubMed ID: 2191806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus.
    Fruchter R; Kurtzman DJB; Patel M; Merola J; Franks AG; Vleugels RA; Femia AN
    JAMA Dermatol; 2017 Sep; 153(9):937-939. PubMed ID: 28636714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.